These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3326922)

  • 1. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review.
    Trost BN; Weidmann P
    J Hypertens Suppl; 1987 Dec; 5(4):S81-104. PubMed ID: 3326922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism and calcium antagonists.
    Trost BN
    Horm Metab Res Suppl; 1990; 22():48-56. PubMed ID: 2202627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of calcium antagonists in humans, with emphasis on carbohydrate, lipid, potassium, and uric acid homeostases.
    Trost BN; Weidmann P
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S86-92. PubMed ID: 2468917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitrendipine and other calcium antagonists on glucose metabolism in man.
    Trost BN; Weidmann P
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S986-95. PubMed ID: 6085390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of calcium antagonists on carbohydrate and lipid metabolism].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa
    Kardiologiia; 1992 Apr; 32(4):84-9. PubMed ID: 1405247
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of diuretics, calcium antagonists, and alpha-blockers on insulin sensitivity and glucose tolerance in hypertensive patients.
    Ramsay LE; Yeo WW; Jackson PR
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S49-53; discussion S53-4. PubMed ID: 1284144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium entry blockers and their effects on glucose metabolism.
    Kingma PJ; Simons JP; Nieuwenhuijzen Kruseman AC; Wolffenbuttel BH
    Neth J Med; 1990 Feb; 36(1-2):32-8. PubMed ID: 2179750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of calcium antagonists on carbohydrate and lipid metabolism in diabetes mellitus].
    Morugova TV; Kamilov FKh; Lazareva DN
    Eksp Klin Farmakol; 1993; 56(2):37-9. PubMed ID: 8348037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
    Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
    Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a role for beta-blockers in hypertensive diabetic patients?
    Tse WY; Kendall M
    Diabet Med; 1994 Mar; 11(2):137-44. PubMed ID: 7911079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Acta Med Scand; 1982; 211(1-2):35-43. PubMed ID: 7041521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists for treatment of diabetes-associated hypertension. Metabolic and renal effects of amlodipine.
    Zanetti-Elshater F; Pingitore R; Beretta-Piccoli C; Riesen W; Heinen G
    Am J Hypertens; 1994 Jan; 7(1):36-45. PubMed ID: 8136109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bepridil on metabolic control and insulin secretion in diabetics.
    Husted SE; Pedersen C; Nielsen HK; Apoil E; Nielsen OH; Lindvig K; Krusell LR; Høegholm A
    Eur J Clin Pharmacol; 1988; 34(3):221-6. PubMed ID: 3294020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose tolerance during antihypertensive therapy in patients with diabetes mellitus.
    Struthers AD; Murphy MB; Dollery CT
    Hypertension; 1985; 7(6 Pt 2):II95-101. PubMed ID: 2867040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on calcium antagonists and the kidney.
    Tobe S
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.